Related Funds
Funds with similar focus
Fund Name | Location |
China Post | Beijing, Beijing, China |
Fangde Zhilian Investment | China, Guangdong, Shenzhen |
Fomou Assets | - |
Glass Capital Management | New Jersey, Saddle River, United States |
Golzern Holding GmbH | - |
Haodao Capital | - |
Investissement Desjardins | Canada, Montréal, Quebec |
Latin Idea Ventures | Distrito Federal, Mexico, Mexico City |
Latour Capital | France, Ile-de-France, Paris |
Leeh Capital | China, Hangzhou, Zhejiang |
Leonis Investissement | - |
Pocket University | China, Jiangsu, Suzhou |
RSM Investments | - |
Spiegel Capital Management | California, San Diego, United States |
Tianjin Woda Guquan Touzi | - |
Tomato Bank | Japan, Okayama, Okayama Prefecture |
Yara ventures | - |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Tvardi Therapeutics | $72M | 15 Jun 2021 | Houston, Texas, United States | ||
Stellanova Therapeutics | $15M | 03 Jun 2021 | Houston, Texas, United States | ||
Asylia Therapeutics | $14M | 25 May 2021 | Houston, Texas, United States | ||
Nirogy Therapeutics | $16M | 26 Jan 2021 | Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Tvardi Therapeutics | $72M | 15 Jun 2021 | Houston, Texas, United States | ||
Stellanova Therapeutics | $15M | 03 Jun 2021 | Houston, Texas, United States | ||
Asylia Therapeutics | $14M | 25 May 2021 | Houston, Texas, United States | ||
Nirogy Therapeutics | $16M | 26 Jan 2021 | Massachusetts, United States |